09-Jul-2024 Marksans Pharma
Based on the recommendation of NRC the Board of Directors has approved the re-appointment of Mr. Abhinna Sundar Mohanty as a Non-Executive Independent Director for a second term of 5 years with effect from July 11 2024 subject to shareholders approval.
16 min read•By Value Research
3 min read•By Dhirendra Kumar
4 min read•By Value Research
Please subscribe to Value Research Premium to unlock the custom duration feature and enhance your experience.
Recommendations for the best investments and allocations that are most optimal for your goal
Backed by research by a team of investment experts with over 30 years of experience
Continuous analysis and support from our team to make sure your goals stay on track
Widely read:
